Wells Fargo & Company Issues Positive Forecast for Healthpeak Properties (NYSE:DOC) Stock Price

Healthpeak Properties (NYSE:DOC) had its price objective boosted by research analysts at Wells Fargo & Company from $18.00 to $20.00 in a report released on Monday,Benzinga reports. The brokerage currently has an “equal weight” rating on the real estate investment trust’s stock. Wells Fargo & Company‘s target price indicates a potential upside of 4.19% from the company’s previous close.

Several other equities analysts have also recently weighed in on the company. Morgan Stanley lifted their target price on Healthpeak Properties from $18.00 to $20.00 and gave the company an “overweight” rating in a research note on Friday, May 22nd. Evercore cut Healthpeak Properties from an “outperform” rating to an “in-line” rating and set a $21.00 target price on the stock. in a research note on Monday, May 11th. Citigroup lifted their target price on Healthpeak Properties from $17.50 to $20.00 and gave the company a “neutral” rating in a research note on Tuesday, May 12th. Scotiabank lifted their target price on Healthpeak Properties from $19.00 to $21.00 and gave the company a “sector perform” rating in a research note on Wednesday, May 27th. Finally, Weiss Ratings raised Healthpeak Properties from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, May 8th. Four research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $19.38.

Healthpeak Properties Trading Up 0.2%

DOC traded up $0.05 during trading on Monday, reaching $19.20. The company had a trading volume of 1,204,275 shares, compared to its average volume of 9,424,629. The firm’s 50-day simple moving average is $17.73 and its 200 day simple moving average is $17.33. The company has a market cap of $13.23 billion, a price-to-earnings ratio of 59.99, a PEG ratio of 2.43 and a beta of 1.05. Healthpeak Properties has a 12-month low of $15.70 and a 12-month high of $20.27. The company has a debt-to-equity ratio of 1.15, a quick ratio of 2.96 and a current ratio of 2.96.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share for the quarter, topping analysts’ consensus estimates of $0.43 by $0.02. The firm had revenue of $752.95 million for the quarter, compared to analysts’ expectations of $694.59 million. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.Healthpeak Properties’s revenue was up 7.1% on a year-over-year basis. During the same quarter last year, the business posted $0.46 EPS. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. Equities research analysts anticipate that Healthpeak Properties will post 1.75 earnings per share for the current year.

Insider Transactions at Healthpeak Properties

In other Healthpeak Properties news, insider Scott R. Bohn sold 10,989 shares of the company’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total transaction of $213,736.05. Following the completion of the sale, the insider owned 7,636 shares of the company’s stock, valued at $148,520.20. This represents a 59.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.23% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of DOC. State Street Corp raised its stake in shares of Healthpeak Properties by 1.8% in the third quarter. State Street Corp now owns 49,498,109 shares of the real estate investment trust’s stock valued at $947,889,000 after purchasing an additional 895,460 shares in the last quarter. JPMorgan Chase & Co. raised its stake in shares of Healthpeak Properties by 8.6% in the fourth quarter. JPMorgan Chase & Co. now owns 30,674,812 shares of the real estate investment trust’s stock valued at $493,251,000 after purchasing an additional 2,438,278 shares in the last quarter. Fuller & Thaler Asset Management Inc. raised its stake in shares of Healthpeak Properties by 19.2% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust’s stock valued at $476,744,000 after purchasing an additional 4,776,056 shares in the last quarter. Geode Capital Management LLC raised its stake in shares of Healthpeak Properties by 0.6% in the fourth quarter. Geode Capital Management LLC now owns 19,534,041 shares of the real estate investment trust’s stock valued at $312,959,000 after purchasing an additional 123,274 shares in the last quarter. Finally, Invesco Ltd. raised its stake in shares of Healthpeak Properties by 9.9% in the fourth quarter. Invesco Ltd. now owns 18,298,776 shares of the real estate investment trust’s stock valued at $294,244,000 after purchasing an additional 1,648,012 shares in the last quarter. 93.57% of the stock is currently owned by institutional investors and hedge funds.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.